unresectable pancreatic carcinoma
Showing 1 - 19 of 19
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +5 more
- Anetumab Ravtansine
- +5 more
-
Birmingham, Alabama
- +44 more
Feb 2, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester
Recruiting
- Advanced Pancreatic Carcinoma
- +9 more
- Endoscopic Ultrasound
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2022
Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8
Recruiting
- Locally Advanced Pancreatic Carcinoma
- +3 more
- Biopsy
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor
Recruiting
- Advanced Lymphoma
- +13 more
- BET Bromodomain Inhibitor ZEN-3694
- +2 more
-
New Haven, ConnecticutYale University Cancer Center LAO
Jun 29, 2022
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022
Gastric Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Unresectable Esophageal Carcinoma Trial in Atlanta (Zinc)
Active, not recruiting
- Gastric Carcinoma
- +3 more
- Zinc
-
Atlanta, Georgia
- +1 more
Apr 1, 2022
Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Pancreatic Adenocarcinoma
- +3 more
- Gemcitabine Hydrochloride
- +5 more
-
Duarte, California
- +3 more
Mar 17, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +51 more
- Dostarlimab
- Niraparib
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 15, 2022
Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)
Active, not recruiting
- Unresectable Pancreatic Carcinoma
- Tocilizumab
- +2 more
-
Herlev, Denmark
- +1 more
Mar 15, 2022
Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte
Recruiting
- Stage III Pancreatic Cancer AJCC v8
- +2 more
- Bosentan
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2021
Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Adavosertib
- +5 more
-
Chicago, Illinois
- +4 more
Jun 10, 2021
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Oxaliplatin
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in Canada, United
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- +3 more
-
Aurora, Colorado
- +4 more
Aug 21, 2017